About Us

About Us

Meaningful, innovative and evidence-based analysis to
help inform key decision making.

Our goal is to be the business intelligence partner of choice for companies in the healthcare arena looking for meaningful, innovative and evidence-based analysis to inform their key decision making. As a trusted and reliable partner, GBI Research helps clients to better understand their business environment, compete successfully within it, and to achieve growth.

At GBI Research, we leverage extensive proprietary databases and employ novel data interrogation methodologies to generate new and meaningful analyses and insights.

Our content and coverage are informed by close collaboration with a global network of domain-specific external partners; this allows us to deliver novel, thought-provoking and idea-generating insights that clients would normally struggle to access.

Our in-house team of researchers and analysts – typically with MBAs, PhDs and MScs, as well as considerable healthcare industry experience is located across the UK, US and Asia Pacific. The team provides expert and insightful commentary to support evidence-based analyses of established and emerging markets.

More than 2,000 clients benefit from the GBI Research product set. Reports are available to purchase as individual research reports or via our online subscription platform, request a demo today to see how it works.

Analyst Views

30 Jun 16
Pharmaceutical R&D in 2016 – Oncology Emerges as a Beacon o....
In this Analyst View, Dominic Trewartha, Managing Analyst for GBI Research, discusses res.....
Read post
22 Jun 16
Combating Antimicrobial Resistance: Can Pharma Step Up to t....
In this Analyst View, Fiona Chisholm, Analyst for GBI Research, discusses antimicrobial d.....
Read post

White Papers

13 Jul 16
Introducing CBR Pharma Insights....
The latest CBR Pharma Insights white paper, Accelerating your Healthcare Insights, discus....
Read post
27 Oct 15
The Obesity Landscape: Obstacles to Current and Future Weig....
This white paper begins by examining the impact of the global obesity epidemic by conside....
Read post

Press Releases

21 Jul 16
Despite 330 Products in the Pipeline, Stem Cell Therapies S....
While steady progress in clinical research and increasing evidence of product effectivene.....
Read post
19 Jul 16
Asia-Pacific Osteoporosis Market Set to Reach $7.7 Billion ....
The osteoporosis market in the Asia-Pacific (APAC) region, which covers India, China, Aus.....
Read post